跳至主要内容
临床试验/NCT00808769
NCT00808769已完成4 期

Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression

Procter and Gamble1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2008年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
The Mean Percent Time Gastric pH > 4.0 on Day 1

研究概览

简要总结

The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Normal subjects who are 18-65 years of age;
  • Non-childbearing potential females or those using birth control

排除标准

  • History of significant GI disease
  • Any significant medical illness
  • History of hypersensitivity, allergy or intolerance to omeprazole or other proton pump inhibitors;
  • Currently using GI medications
  • GI disorder or surgery leading to impaired drug absorption

研究组 & 干预措施

1

Active Comparator

Zegerid®

干预措施: Zegerid® (Drug)

2

Experimental

Prilosec OTC®

干预措施: Prilosec OTC® (Drug)

结局指标

主要结局

The Mean Percent Time Gastric pH > 4.0 on Day 1

时间窗: continuously over a 24 hour period

In this study, there was evidence of gastric pH probe failure and a high incidence of biologically improbable pH measurements (sustained pH \< 1.0) that bring the validity of the results into question. The results of this study are, therefore, inconclusive.

次要结局

未报告次要终点

研究者

发起方
Procter and Gamble
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Comparison of Prilosec OTC® Versus Zegerid® for... | 临床试验